肠道LKB1缺失驱动锯齿状结直肠癌癌前程序
该研究利用CRISPR/Cas9构建Lkb1杂合及纯合缺失的小鼠小肠和人结肠类器官,结合影像、bulk及单细胞RNA测序和生长因子依赖性实验,发现杂合Lkb1缺失足以使肠上皮细胞进入与锯齿状结直肠癌相关的癌前转录程序,并在杂合性丢失后放大;该程序富集于散发性锯齿状结直肠癌,且与突变Kras协同促进类器官生长。
要点
- 杂合Lkb1缺失即可启动锯齿状结直肠癌相关癌前转录程序。
- 该癌前状态表现为持续再生特征和增强的EGFR配体/受体表达。
- LKB1突变特征在散发性锯齿状结直肠癌中富集,且与突变Kras协同。
核心结论
- 杂合LKB1缺失使肠上皮细胞进入慢性再生状态,杂合性丢失后放大,为锯齿状结直肠癌发生提供土壤,可能解释PJS患者癌症风险增加。
研究设计与样本
- 使用CRISPR/Cas9构建杂合和纯合Lkb1缺失的小鼠小肠及人结肠类器官,采用影像、bulk和单细胞RNA测序及生长因子依赖性实验进行表征。
- 在人类PJS来源组织中用免疫组化验证发现,并利用TCGA癌症数据库将结果与结直肠癌图谱关联。
主要发现
- 杂合Lkb1缺失足以推动肠细胞进入与锯齿状结直肠癌相关的癌前转录程序,该程序被杂合性丢失进一步放大。
- 该改变的上皮生长状态与持续再生特征及增强的EGFR配体和受体表达相关,赋予Lkb1缺失类器官不依赖微环境的生长特性。
- 新构建的LKB1突变特征在散发性锯齿状结直肠癌中富集,且通过评估类器官生长特性和转录组实验证实Lkb1缺失与突变Kras协同合作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Heterozygous inactivating mutations of Serine Threonine Kinase 11/Liver Kinase B1 (LKB1) are causative to the Peutz-Jeghers syndrome (PJS), a hereditary disease characterized by gastrointestinal hamartomatous polyposis and increased cancer susceptibility. Although LKB1 loss-induced polyp formation has been ascribed to nonepithelial tissues, how LKB1 deficiency increases cancer risk of patients by altering the phenotypical landscape and hierarchical organization of epithelial tissues remains poorly understood. METHODS: Using CRISPR/Cas9, we generated heterozygous and homozygous Lkb1-deficient mouse small intestinal and human colon organoids. These organoids were characterized by an integrated approach that combines imaging, bulk and single-cell RNA sequencing, and growth factor dependency assays. Our findings were validated in human PJS-derived tissues using immunohistochemistry and linked to colorectal cancer profiles using the Cancer Genome Atlas (TCGA) cancer database. RESULTS: Our results reveal that heterozygous Lkb1 loss is sufficient to push intestinal cells into a premalignant transcriptional program associated with serrated colorectal cancer, which is further amplified by loss of heterozygosity. This altered epithelial growth state associates with persistent features of regeneration and enhanced EGFR ligand and receptor expression, conferring niche-independent growth properties to Lkb1-deficient organoids. Moreover, our newly generated LKB1-mutant signature is enriched in sporadic serrated colorectal cancer, and synergistic cooperation of Lkb1 deficiency with mutant Kras was experimentally confirmed by assessing organoid growth properties and transcriptomes. CONCLUSIONS: Heterozygous loss of LKB1 pushes intestinal cells into a chronic regenerative state, which is amplified on loss of heterozygosity. Lkb1 deficiency thereby generates fertile ground for serrated colorectal cancer formation in the intestine, potentially explaining the increased cancer risk observed in PJS.
引用
- Plugge SF, Ma H, van der Vaart JY, et al. Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway. Gastroenterology. 2025. PMID: 41128695. doi:10.1053/j.gastro.2025.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。